Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.

J, Stumpf; T, Siepmann; T, Lindner; C, Karger; J, Schwöbel; L, Anders; R, Faulhaber-Walter; J, Schewe; H, Martin; H, Schirutschke; K, Barnett; J, Hüther; P, Müller; T, Langer; T, Pluntke; K, Anding-Rost; F, Meistring; T, Stehr; A, Pietzonka; K, Escher; S, Cerny; H, Rothe; F, Pistrosch; H, Seidel; A, Paliege; J, Beige; I, Bast; A, Steglich; F, Gembardt; F, Kessel; H, Kröger; P, Arndt; J, Sradnick; K, Frank; A, Klimova; R, Mauer; X, Grählert; M, Anft; A, Blazquez-Navarro; TH, Westhoff; U, Stervbo; T, Tonn; N, Babel; C, Hugo

doi:10.1016/j.lanepe.2021.100178

Public

Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.

Shared by NobleBlocks on Jul 23, 2021 • 12:00 AM UTC

Authors:

Stumpf J

Siepmann T

Lindner T

Abstract

Background Dialysis and kidney transplant patients are vulnerable populations for COVID-19 related disease and mortality.Methods We conducted a prospective study exploring the eight week time course of specific cellular (interferon-γ release assay and flow cytometry) or/and humoral immune responses ...

Subject

Medical personnel

epidemiology

Guidelines

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!